The report on the Global Human Embryonic Stem Cells Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Drivers
- Increasing R&D activities in toxicology testing
- Advancements in technology for the production of embryonic stem cells
Restraints
- Ethical concerns associated with stem cell research
Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:
- Base Year: 2019
- Estimated Year: 2020
- Forecast Till: 2026
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
The report classifies the market into different segments based on application. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
The report also covers the complete competitive landscape of the global Human Embryonic Stem Cells market with company profiles of key players such as:
- Astellas Pharma Inc.
- Biotime, Inc.
- CellGenix GmbH
- Cordlife Group Limited
- Cynata Therapeutics Limited
- ESI BIO Stem Cell Solution
- Genea Biocells US Inc.
- Geron Corporation
- International Stem Cell Corporation
- Kite Pharma Inc.
- LifeCell International Pvt. Ltd.
- Lonza Group
- PromoCell GmbH
- STEMCELL Technologies Inc.
- Sumanas, Inc.
- Thermo Fisher Scientific, Inc.
A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
SEGMENTATIONS IN THE REPORT:
By Applications:
- Regenerative Medicine
- Stem Cell Biology Research
- Tissue Engineering
- Toxicology Testing
By Geography:
- North America (NA)
- Europe (EU)
- Asia Pacific (APAC)
- Latin America (LA)
- Middle East & Africa (MEA)
The Global Human Embryonic Stem Cells Market has been exhibited in detail in the following chapters -
Chapter 1 Human Embryonic Stem Cells Market Preface
Chapter 2 Executive Summary
Chapter 3 Human Embryonic Stem Cells Industry Analysis
Chapter 4 Human Embryonic Stem Cells Market Value Chain Analysis
Chapter 5 Human Embryonic Stem Cells Market Analysis By Applications
Chapter 6 Human Embryonic Stem Cells Market Analysis By Geography
Chapter 7 Competitive Landscape Of Human Embryonic Stem Cells Companies
Chapter 8 Company Profiles Of Human Embryonic Stem Cells Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.